The Safety and Efficacy of Second-line Single Docetaxel (75 mg/m(2)) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated with Platinum-based Chemotherapy

PURPOSE: When used in the second-line setting, single-agent chemotherapy has produced response rates of more than 10% or median survival times greater than 4 months. We studied the safety and efficacy of using second-line single docetaxel (75 mg/m(2)) for advanced NSCLC patients who were previously...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shim, Byoung Yong, Kim, Chi Hong, Song, So Hyang, Ahn, Meyung Im, Hong, Eun Jung, Kim, Sung Whan, Kim, Suzy, Jo, Min Seop, Cho, Deog Gon, Cho, Kyu Do, Yoo, Jinyoung, Kim, Hoon-Kyo
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2005
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2785941/
https://ncbi.nlm.nih.gov/pubmed/19956369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2005.37.6.339
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados